Senologie - Zeitschrift für Mammadiagnostik und -therapie 2022; 19(02): e39
DOI: 10.1055/s-0042-1748441
Abstracts | DGS

Breast cancer, subclavian port catheter and controlled ovarian stimulation (COS): a case report highlighting a challenging combination for fertility protection

A. Stefan
1   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und Comprehensive Cancer Center (CCC) München LMU, München, Deutschland
,
D. Dziura
2   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum der LMU, München, Deutschland
,
A. König
1   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und Comprehensive Cancer Center (CCC) München LMU, München, Deutschland
,
R. Würstlein
1   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und Comprehensive Cancer Center (CCC) München LMU, München, Deutschland
,
N. Harbeck
1   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Brustzentrum und Comprehensive Cancer Center (CCC) München LMU, München, Deutschland
,
C.J. Thaler
2   LMU Klinikum, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Hormon- und Kinderwunschzentrum der LMU, München, Deutschland
› Author Affiliations
 
 

    Aims This report points to an elevated risk of thromboembolism in a breast cancer patient, who, in preparation of neoadjuvant chemotherapy, received a port catheter. For fertility protection, COS and oocyte retrieval was planned. This combination of prothrombotic risk factors ought to be considered for LMWH-prophylaxis.

    Material, methods We report on a 39-year-old nulliparous woman with HR+/HER2- early breast cancer (cT1c, cN0, G3, Ki67 60%, cM0). BMI was normal, no personal or family-related risk factors were known. Ovarian reserve was poor (AFC 5, AMH 0.63ng/ml). In preparation for neoadjuvant chemotherapy, a port catheter was implanted in the left subclavian vein; the procedure was uneventful. For fertility protection, she was started on COS using an antagonist protocol (rec-FSH, HMG, Ganirelix) in combination with letrozole given her HR-positive cancer. Ten days later she presented with pain and heaviness of her left arm; estradiol-level was 347pg/ml at this time.

    Results Doppler-sonography revealed a thrombosis of the port catheter; consequently, anticoagulation with LMWH was started in a therapeutic dosage. Despite this event, ovulation was induced with a GnRH-trigger and ultrasound-guided oocyte retrieval was performed. A total of three metaphase-II-oocytes was vitrified. On the following day the first cycle of neoadjuvant chemotherapy was administered complication-free using the port catheter. Therapeutic anticoagulation was continued for three months.

    Summary This case highlights the relevance of a combination of several prothrombotic effects: cancerous disease, venous access device and supraphysiologic estradiol concentrations caused by COS. In such cases, adequate prophylactic measures should be considered even without further risk factors.


    #

    Interessenskonflikt

    Ich erkläre als korrespondierender Autor, dass meine Koautoren mir mitgeteilt haben, dass sie während der letzten 3 Jahre keine wirtschaftlichen oder persönlichen Verbindungen im oben genannten Sinne hatten. Auch ich selbst hatte keine derartigen Verbindungen in den letzten 3 Jahren.

    Publication History

    Article published online:
    21 June 2022

    © 2022. Thieme. All rights reserved.

    Georg Thieme Verlag
    Rüdigerstraße 14, 70469 Stuttgart, Germany